Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,267 across all filing types
Latest filing 2020-06-04 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended March 31, 2020, pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. It contains detailed financial data on transactions with related parties, including purchases, sales, reimbursements, contributions to trusts, and balances receivable and payable. The document is addressed to stock exchanges and is a regulatory compliance disclosure. It is not an annual or interim report, audit report, or earnings release. It is a regulatory filing specifically disclosing related party transactions as required by SEBI regulations. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is 5929 characters, which is sufficient to contain substantive data, not just an announcement or certification.
2020-06-04 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the completion of dispatch of postal ballot notices and publication of related newspaper advertisements. It references a Postal Ballot Notice dated May 23, 2020, and mentions that the notices were sent to shareholders and advertisements were published. The document is short (1475 characters) and serves as an announcement of the dispatch and publication related to a shareholder voting process. It does not contain any financial data, voting results, or detailed meeting materials. Therefore, it is not a full report like an Annual Report or Interim Report, nor is it a Declaration of Voting Results. It is an announcement related to shareholder voting procedures, specifically the dispatch of postal ballot notices and related advertisements. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-05-28 English
We refer to our Letter dated May 27, 2020, wherein AstraZeneca Pharma India Limited ('the Company') had uploaded the Postal Ballot Notice with the Stock Exchanges. In continuation, ....
Regulatory Filings
2020-05-28 English
We are enclosing herewith the Postal Ballot Notice dated May 23, 2020 being sent to the Members of the Company to their registered email address, seeking approval of the members for the ....
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated May 23, 2020, sent to shareholders of AstraZeneca Pharma India Limited. It details the process for remote e-voting on special resolutions, including alteration of the Memorandum and Articles of Association. It references compliance with the Companies Act, 2013, SEBI Listing Regulations, and related circulars. The document is a notice to shareholders to vote on corporate governance matters via postal ballot and e-voting, not the results of the vote or a report of the vote outcome. It is not a full report like an Annual Report or Interim Report, nor is it a management discussion or earnings release. It is a solicitation and information statement for shareholder voting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial and contains detailed instructions and explanatory statements, consistent with PSI filings.
2020-05-27 English
Updates
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice dated May 23, 2020, sent to shareholders of AstraZeneca Pharma India Limited. It details the process for remote e-voting on special resolutions, including alteration of the Memorandum and Articles of Association. It references compliance with the Companies Act, 2013, SEBI Listing Regulations, and related circulars. The document is a notice seeking shareholder approval via postal ballot and remote e-voting, not the results or a report of the voting. It is not a full report like an Annual Report or Interim Report, nor is it a voting results declaration. It is a solicitation and information statement for voting purposes. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full notice, not just an announcement of a report. Confidence is high due to clear identification of the document as a Postal Ballot Notice with explanatory statement and voting instructions.
2020-05-27 English
Updates
Regulatory Filings Classification · 95% confidence The document text contains only references to omitted pictures and no substantive text content. The true document length is only 218 characters, which is very short and does not contain any financial data, report content, or announcements. There is no indication of the document being a report itself or an announcement of a report. Given the lack of content and the very short length, this document does not fit into any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2020-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.